ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions

Core Points - ONWARD Medical N.V. is a medical technology company focused on developing spinal cord stimulation therapies to restore movement and independence for individuals with spinal cord injuries and other movement disabilities [1][3] - The company will hold its 2025 Annual General Meeting of Shareholders (AGM) on June 11, 2025, in Amsterdam, with a record date for participation set for May 14, 2025 [1][2] Company Overview - ONWARD Medical has developed ARC Therapy, which has received ten Breakthrough Device Designations from the US FDA, and its ARC-EX System is cleared for commercial sale in the US [3] - The company is also working on an investigational implantable system called ARC-IM, which may include a brain-computer interface [3] - The company is headquartered in the Netherlands, with additional facilities in Switzerland and a US office in Boston, Massachusetts [4] AGM Resolutions - Key resolutions proposed for the AGM include the adoption of annual accounts for the financial year 2024, implementation of the compensation policy for 2024, and the appointment of new non-executive directors [4] - The board seeks authorization to issue ordinary shares and acquire shares in the company's capital, with specific limits on the percentage of issued share capital [4]